Well thanks to the LSE listing after 4 years I have been handed...

Well thanks to the LSE listing after 4 years I have been handed a golden opportunity by ill informed new investors to exit at a profit a few k above what I lost on the MXC options a year or so ago. The only redeeming factor that kept me in was the heart surgeon Walker who still sits on the board. Al I will say is that new investors must know very little about the background of the company, the failed deals, the low performance criteria needed to produce performance shares, the high salaries paid at shareholders expense, the sustainability of future cash flows that are still well below meeting fixed overheads, the future competition in producing CBD, trials which are never ending and a significant amount more data that needs to be produced to verify in any meaningful way a solution to the health outcomes they are claiming. I recall that Cannipil was going to produce millions of dollars 3 years ago.
Good luck and goodbye